Introducing a national essential diagnostics list in India.
作者信息
Vijay Sonam, Gangakhedkar Raman R, Shekhar Chander, Walia Kamini
机构信息
Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, Ansarinagar, New Delhi, 110029, India.
Division of Innovation and Translational Research, Indian Council of Medical Research, New Delhi, India.
出版信息
Bull World Health Organ. 2021 Mar 1;99(3):236-238. doi: 10.2471/BLT.20.268037. Epub 2020 Nov 30.
Abstract
摘要
相似文献
1
Introducing a national essential diagnostics list in India.在印度引入一份国家基本诊断清单。
Bull World Health Organ. 2021 Mar 1;99(3):236-238. doi: 10.2471/BLT.20.268037. Epub 2020 Nov 30.
2
Comparison of essential drug list in a rural secondary care hospital in south India with Indian & World Health Organization list 2011.印度南部一家农村二级护理医院的基本药物清单与2011年印度及世界卫生组织清单的比较。
Indian J Physiol Pharmacol. 2012 Oct-Dec;56(4):375-81.
3
A critical look at the ophthalmological preparations in the national list of essential medicines of India 2011.审视2011年印度基本药物国家清单中的眼科制剂
J Postgrad Med. 2013 Apr-Jun;59(2):159-60. doi: 10.4103/0022-3859.113812.
4
The World Health Organization's Essential Diagnostics List: Diagnostics for neurologic disorders.世界卫生组织基本诊断清单：神经系统疾病的诊断方法
Neurology. 2019 Oct 8;93(15):680-683. doi: 10.1212/WNL.0000000000008247.
5
National list of essential medicines of India: the way forward.印度基本药物国家清单：前进之路。
J Postgrad Med. 2012 Jan-Mar;58(1):68-72. doi: 10.4103/0022-3859.93258.
6
Essential diagnostics and devices in primary care diabetes.基层医疗中糖尿病的基本诊断和设备
J Pak Med Assoc. 2021 Sep;71(9):2281-2282.
7
Essential medicines lists for children of WHO, India, South Africa, and EML of China: A comparative study.世界卫生组织、印度、南非和中国基本药物清单：比较研究。
J Evid Based Med. 2017 Nov;10(4):271-280. doi: 10.1111/jebm.12240. Epub 2017 May 24.
8
Availability of Pediatric Formulations in Public Health Care System in India: A Case Study.印度公共医疗体系中儿科制剂的供应情况：案例研究。
Indian J Pediatr. 2021 Mar;88(3):227-234. doi: 10.1007/s12098-020-03220-3. Epub 2020 Feb 21.
9
Could the WHO model list of essential medicines do more for the safe and appropriate use of injections?世界卫生组织基本药物示范清单能否在注射剂的安全合理使用方面发挥更大作用？
J Clin Pharmacol. 2004 Oct;44(10):1106-13. doi: 10.1177/0091270004268410.
10
On Essentiality and the World Health Organization's Model List of Essential Medicines.论必需性和世界卫生组织基本药物标准清单
Ann Glob Health. 2017 May-Aug;83(3-4):637-640. doi: 10.1016/j.aogh.2017.05.005. Epub 2017 Jun 22.
引用本文的文献
1
Advocating for the inclusion of therapeutic drug monitoring in the national essential diagnostic list: Perspectives from psychiatrists.倡导将治疗药物监测纳入国家基本诊断清单：精神科医生的观点。
Indian J Psychiatry. 2024 Jul;66(7):660-664. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_330_24. Epub 2024 Jul 17.
2
Situational Analysis of Healthcare and Medical Diagnostic Testing Facility Availability in Selected Blocks of Muzaffarpur District, Bihar, India: A Cross-Sectional Study.印度比哈尔邦穆扎法尔布尔区部分街区医疗保健与医疗诊断检测设施可及性的现状分析：一项横断面研究
Cureus. 2023 Sep 26;15(9):e46037. doi: 10.7759/cureus.46037. eCollection 2023 Sep.
3
Strengthening health systems through essential diagnostic lists and diagnostic network optimization.通过基本诊断清单和诊断网络优化加强卫生系统。
PLOS Glob Public Health. 2023 Mar 30;3(3):e0001773. doi: 10.1371/journal.pgph.0001773. eCollection 2023.
4
Implementing essential diagnostics-learning from essential medicines: A scoping review.实施基本诊断——借鉴基本药物的经验：一项范围综述
PLOS Glob Public Health. 2022 Dec 19;2(12):e0000827. doi: 10.1371/journal.pgph.0000827. eCollection 2022.
5
Rational design of an essential diagnostics network to support Universal Health Coverage: a modeling analysis.支持全民健康覆盖的基本诊断检测网络的合理设计：建模分析。
BMC Health Serv Res. 2022 Oct 1;22(1):1224. doi: 10.1186/s12913-022-08558-2.
6
Understanding complexities in the uptake of indigenously developed rapid point-of-care diagnostics for containment of antimicrobial resistance in India.理解印度为遏制抗微生物药物耐药性而采用本土研发的即时检测快速诊断技术所面临的复杂性。
BMJ Glob Health. 2021 Sep;6(9). doi: 10.1136/bmjgh-2021-006628.
本文引用的文献
1
Typhoid fever: Control & challenges in India.伤寒：印度的控制与挑战。
Indian J Med Res. 2019 Nov;150(5):437-447. doi: 10.4103/ijmr.IJMR_411_18.
2
Availability of essential diagnostics in primary care in India.印度初级医疗保健中基本诊断方法的可及性。
Lancet Infect Dis. 2018 Oct;18(10):1064-1065. doi: 10.1016/S1473-3099(18)30539-5.
3
Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study.一国之内的差异：1990-2016 年印度各邦的疾病流行转变的流行病学差异，全球疾病负担研究。
Lancet. 2017 Dec 2;390(10111):2437-2460. doi: 10.1016/S0140-6736(17)32804-0. Epub 2017 Nov 14.
4
Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platform.应对诊断供需挑战：来自一个在线全球健康讨论平台的见解
BMJ Glob Health. 2016 Dec 2;1(4):e000132. doi: 10.1136/bmjgh-2016-000132. eCollection 2016.
5
Assessment of primary care facilities for cardiovascular disease preparedness in Madhya Pradesh, India.印度中央邦心血管疾病防范初级保健设施评估
BMC Health Serv Res. 2015 Sep 23;15:408. doi: 10.1186/s12913-015-1075-x.
6
Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem.抗菌药物耐药性：抗生素过度使用相关风险及解决措施。
Ther Adv Drug Saf. 2014 Dec;5(6):229-41. doi: 10.1177/2042098614554919.
7
When do vertical programmes strengthen health systems? A comparative assessment of disease-specific interventions in India.垂直项目何时能加强卫生系统？对印度特定疾病干预措施的比较评估。
Health Policy Plan. 2014 Jul;29(4):495-505. doi: 10.1093/heapol/czt035.
Zotero 插件